SUMMARY Total body potassium (OK) and leucocyte potassium measurements were carried out on 19 patients with stable but decompensated cirrhosis maintained on diuretics for previous ascites. Of 13 patients receiving spironolactone alone none had a total body potassium below the expected lower limit of normal, whereas, of six receiving additional frusemide, two had low values. The results for leucocyte potassium were in agreement and simultaneous measurements of leucocyte magnesium showed a close correlation, those with intracellular potassium depletion also having magnesium depletion. One such patient was treated with magnesium supplements without effect on the potassium, although intracellular magnesium was improved. It is concluded that spironolactone alone is the treatment of choice in the maintenance management of such patients; that additional potassium would be unnecessary; and that additional frusemide should be avoided if possible.
Hypokalaemia has long been recognised as an undesirable development in chronic liver disease and, if induced by diuretics such as chlorothiazides, hepatic encephalopathy may be precipitated (Read et al., 1959) . The serum potassium concentration, however, is an insensitive indicator of total body content. Measurement of total exchangeable potassium has provided evidence of potassium depletion, even with normal serum levels, both in uncomplicated cirrhosis occasionally, and more frequently in the presence of oedema and ascites (Aikawa et al., 1953; Nagant de Deuxchaisnes et al., 1961; Casey et al., 1965; Traverso et al., 1966.) There are a number of inaccuracies with this technique, however, and it correlates poorly (Surveyor and Hughes, 1968 ) with the more recently described and precise method based on estimation of the total body natural isotope (40K). Another way of assessing potassium status is by direct measurement of intracellular potassium content using isolated leucocyte preparations (Baron and Ahmed, 1969) , and in this paper we describe the use of both measurements to investigate potassium status in patients with advanced chronic liver disease established on long-term diuretic therapy. Leucocyte magnesiumwas measured simultaneously with leucocyte potassium to determine whether magnesium depletion occurred in Received for publication 9 February 1977 association with potassium depletion, and in such cases to determine whether improvement in the latter could best be obtained by the addition of oral magnesium supplements as has been observed by other workers (Lim and Jacob, 1972b) .
Methods
The 19 patients investigated comprised seven with alcoholic cirrhosis, four with cryptogenic cirrhosis. four with primary biliary cirrhosis, and four with active chronic hepatitis. In all patients ascites had been present during the previous year, requiring treatment with diuretics which had to be continued to prevent recurrence. Selection of patients was on the grounds of clinical condition, and they were mostly outpatients and fit enough to travel to Northwick Park Hospital by car for measurements of total body potassium. However, all the patients had severe disease with evidence of hepatic decompensation in addition to their formerascites (Table 1) . Of those with varices, cases 1, 4, 5, 6, 9, 12. 16, 18 , and 19 had bled previously, and since the time of study four have died and one has undergone transplantation.
The diuretic regime at the time of study consisted of a potassium-sparing agent (18 spironolactone, one amiloride), and six of these patients were on additional frusemide. The latter patients were also 683 684~~~~~~~~~~~~~~~~~~~~~P. G. Wheeler, et al. (Smith and Cronquist, 1976) . Each patient was measured for 1000 seconds, and a background measurement using a distilled water phantom was also made for the same time both before and after that on the patient. A KCI phantom containing 1400 g K was also measured to allow corrections for any minor variations in counting efficiency. The counter had previously been calibrated by the 42K technique (Burkinshaw, 1967) in groups of male and female subjects covering a wide range in weight. Errors arising from counting statistics and the use of the calibration curve led to a coefficient of variation between 2-8 % and 5-4 %. Observed TBK values (K obs) were compared with expected normal values (K exp). In all but two patients, expected values for TBK were calculated using equations expressing the multiple regression of TBK in normal adults on height, weight, and age (Boddy et at., 1972) . The expected value has a variation (2 SD from regression) of ± 15% and therefore potassium depletion was taken to be indicated by a K obs/K exp ratio less than 0-85. The body weights of two of our patients were less than 80 % of those expected for their heights and ages (Society of Actuaries, 1959) and, therefore, their K exp values were estimated using a regression equation based on weight only (Edmonds et al., 1975) . This has been shown to be more appropriate for underweight individuals than an equation based on both height and weight.
The electrolyte content of leucocytes was estimated after dextran sedimentation and hypo-osmotic lysis of erythrocytes in a specimen of heparinised venous blood, according to the method of Baron and Ahmed (1969) . Sodium although two had been on a dose of only 40 mg daily for less than three weeks. All patients receiving spironolactone alone had a normal total body potassium, although two of these were close to the lower limit of normal (Fig. 1) .
Simultaneous measurement of leucocyte potassium content was carried out on 15 of the 19 patients, including the two with a depleted total body potassium.Values were within the normal range in 12, leaving only three with a leucocyte potassium content indicative of total body depletion. One of these was just below the lower limit of normal. The second was one of the two cases who also showed a depleted total body potassium, the other of these having a normal leucocyte potassium. The third had a reduced leucocyte potassium with a normal total body potassium. Thus, in only two patients out of the 15 in whom both techniques had been employed, was there definite discrepancy between the results. Potassium and magnesium depletion in patients with cirrhosis on maintenance diuretic regimes The correlation between leucocyte magnesium and potassium content was statistically highly significant (r = 0-84, p < 0-001) (Fig. 2) . One patient with a slight reduction in leucocyte potassium but a high leucocyte magnesium was found to have been receiving magnesium sulphate by enema until a week before study.
EFFECT OF MAGNESIUM SUPPLEMENTS
The one patient who was potassium depleted on the basis of both total body and leucocyte measurements also had a low leucocyte magnesium, and repeat investigations were carried out after administration of oral magnesium supplements in a dose of 30 mmol daily for one month. During this time she continued on spironolactone 100 mg daily, frusemide 40 mg daily, and potassium 16 mmol daily as before (Table 2) . Although the leucocyte magnesium content returned to normal in the space of this month, the total body potassium and leucocyte potassium remained abnormally low. Indeed, there was very close agreement between these two measures of potassium status one month apart (Table 2) . 
Discussion
The low incidence of potassium depletion found in our patients contrasts with that in a recent study (Soler et al., 1976) in which over 50% of a series of patients with cirrhosis had a low total body potassium (40K). Twelve out of 18 patients on diuretic treatment had low values, whereas only 17 out of 37 patients not receiving diuretics had evidence of potassium depletion. The diuretic regimes differed in that our patients mostly received spironolactone alone, whereas those of Soler et al. were on a potassium-losing diuretic such as frusemide or chlorothiazide in addition to spironolactone. Combinations of potassium-sparing and potassium-losing diuretics still entail a risk of potassium depletion (Yamada and Reynolds, 1970 
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65b alone has been said to induce potassium depletion in patients with liver disease (Levy et al., 1970; Vesin, 1975) .
None of our own patients had clinically detectable ascites at the time of study. If some had been present, total body potassium measurements would have been underestimated unless adequate correction was made for the body weight that was higher than expected. In patients with obvious ascites it is likely that there would be a falsely high incidence of depleted values even if correction for ascitic volume is made, as measurement of this volume is difficult, being easily underestimated. This could, in part, account for the large number of potassium depleted patients in some series.
In our group of patients there is agreement between leucocyte potassium and total body potassium in the majority of cases, with only two discrepancies. A correlation has been shown between the leucocyte technique and total exchangeable potassium (42K) in animals (Patrick and Bradford, 1972) , but in the presence of spironolactone or the metabolic effects of decompensated liver disease, it is not inconceivable that exceptions might occur because of a direct effect on sodium-potassium exchange at the cell membrane, giving a different intracellular result from a total body value.
The close correlation between leucocyte potassium and magnesium content found in our patients is in agreement with the concept of a stable equilibrium of all intracellular cations with relatively fixed ratios between them (Wacker and Parisi, 1968) . This confirms observations on skeletal muscle in patients with cirrhosis (Lim and Jacob, 1972a) and on muscle and erythrocytes in the experimental animal (Whang and Welt, 1963) . Diuretics may produce cellular magnesium depletion as well as potassium depletion and an improvement in potassium level is said to be greatest when magnesium is added to the oral potassium supplements (Lim and Jacob, 1972b ). This was not our experience in the single patient reported in this paper. Further studies were not possible in view of the very low number of such potassium depleted patients.
In a different group of cirrhotic patients with marked sodium retention and accumulation of ascites investigated before diuretic treatment, we found significant reductions in leucocyte potassium content compared with similar patients without ascites (Alam et al., 1976) . The same situation is likely to have existed in the present group of patients before treatment.
In conclusion, it would appear that the likelihood of developing potassium depletion is small in patients with cirrhosis and ascites who have undergone initial diuretic treatment, when control can be maintained by spironolactone alone. The need for additional potassium supplements is then not only unnecessary but could be followed by dangerously high blood levels.
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